Faith L. Charles - Dec 30, 2022 Form 3 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-fact
Stock symbol
CNSP
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
3
Date filed
1/4/2023, 03:01 PM
Previous filing
Sep 28, 2022
Next filing
Jun 16, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney